Abemaciclib metabolite M20 是 Abemaciclib 的活性代谢物,是一种选择性 CDK4/6 抑制剂,可用于癌症的相关研究
此产品仅用于科学研究,我们不为任何个人用途提供产品和服务
Abemaciclib metabolite M20 (LSN3106726), the active metabolite of Abemaciclib, is a selective?CDK4/6?inhibitor for the treatment of cancer[1]
[1]. Richard Paul Beckmann, et al. Combination therapy with notch and cdk4/6 inhibitors for the treatment of cancer. WO2017180389A1.